HLG The Week In Review 10.19

Canada Legalizes, Colorado's Amendment X, FDA Says Marijuana Ingredient CBD Doesn’t Meet Criteria For Federal Control

This Week in Review

Canadians linked to newly legal pot industry could be barred from US

More than 100 recreational marijuana stores will open across Canada this week, bringing opportunities for international business and tourism — and creating potential conflict with U.S. authorities as money and people flow across the border. Read more

Will Amendment X Keep Hemp Competitive, or Shut Out Small Growers?

Colorado voters could approve a measure this November that will take industrial hemp out of the Colorado Constitution. Many hemp-industry members and growers say it's a necessary move to keep the state competitive. Many, but not all. Read more

Trump Administration Seeks Public Comments On Marijuana Reclassification

The federal government wants your input on whether marijuana should be reclassified under global drug treaties to which the U.S. is a party. Specifically, the U.S. Food and Drug Administration (FDA) is asking for public comments about the "abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use" of cannabis and several other substances now under international review. Read more

FDA Says Marijuana Ingredient CBD Doesn’t Meet Criteria For Federal Control

Last week’s decision by the U.S. Drug Enforcement Administration (DEA) to place a marijuana-derived drug in the least restrictive category under federal law was largely based on a recommendation from the Food and Drug Administration (FDA). But according to a recently released internal government letter, the FDA actually concluded that cannabidiol, or CBD, doesn’t meet the criteria for federal control at all. Read more